Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions ; volume:18 ; number:1 ; day:4 ; month:1 ; year:2021 ; pages:1-6 ; date:12.2021
Virology journal ; 18, Heft 1 (4.1.2021), 1-6, 12.2021
- Urheber
-
Zheng, Yue
Larragoite, Erin T.
Williams, Elizabeth S. C. P.
Lama, Juan
Cisneros, Isabel
Delgado, Julio C.
Slev, Patricia
Rychert, Jenna
Innis, Emily A.
Coiras, Mayte
Rondina, Matthew T.
Spivak, Adam M.
Planelles, Vicente
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-020-01472-1
- URN
-
urn:nbn:de:101:1-2021020601133113065640
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zheng, Yue
- Larragoite, Erin T.
- Williams, Elizabeth S. C. P.
- Lama, Juan
- Cisneros, Isabel
- Delgado, Julio C.
- Slev, Patricia
- Rychert, Jenna
- Innis, Emily A.
- Coiras, Mayte
- Rondina, Matthew T.
- Spivak, Adam M.
- Planelles, Vicente
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Stokes–Mueller polarization-based analysis of model SARS-CoV-2 virions
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
SARS-CoV-2 und Medikamenten
Neuartiges Coronavirus (SARS-CoV-2)
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Stokes–Mueller polarization-based analysis of model SARS-CoV-2 virions
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
SARS-CoV-2 und Medikamenten
Neuartiges Coronavirus (SARS-CoV-2)
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Stokes–Mueller polarization-based analysis of model SARS-CoV-2 virions
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
SARS-CoV-2 und Medikamenten